Myocardial Infarction
Conditions
Keywords
Cardiovascular diseases, Heart diseases, Myocardial infarction, Rehabilitation, Health Economy, Randomized controlled trials, Non ST Elevation Myocardial Infarction (NSTEMI), Cost analysis, Sick-leave, Quality of Life
Brief summary
In this study the investigators aim at comparing the effect on quality of life and the cost-effectiveness of a structuralised sick-leave program compared to usual care sick leave management in patients after an acute non ST myocardial infarction(NSTEMI).The investigators hypothesize that a structuralised sick-leave program after an acute NSTEMI is cost-effective without a negative effect on quality of life compared to usual care management in this patient group.
Interventions
Patients randomized to usual care. Follow up after discharge by general practitioner (GP) according to local practice.
Patients randomized to the structuralized program will get full time sick-leave for 2 weeks after discharge.Cardiologist will be responsible for individual adaption of each patient's sick-leave and follow-up.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with acute NSTEMI who are revascularized. * 65 years old or less * Self caring * Adequately literate in Norwegian * Have a regular work in at least 50% position.
Exclusion criteria
* Patients not willing to participate * Professional drivers * Patients with alcohol or drug abuse * Severe complications after the myocardial infarction such as malignant arrythmias, heart failure and major bleedings. * Patients with recent CABG ( coronary artery bypass graft operation) within the last 6 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cost effectiveness | one year | In order to evaluate resource use (costs) all patients will be asked to fill in a questionnaire at baseline and after 6 and 12 months. Total costs and mean costs will be calculated in the two different follow-up modalities. |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life measures are estimated at baseline and after 6 and 12 months using the standard Medical Outcomes Study Short form( SF-36)questionnaire and the disease-specific Utility-Based Quality of life-Heart questionnaire(UBQ-H). | one year |
Countries
Norway